Rxsight Inc (RXST) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Rxsight Inc   (NASDAQ: RXST)

Select the Financial Report: Select the Period:


Description of Rxsight Inc's Business Segments


Rxsight Inc. is a healthcare technology company that focuses on transforming the patient experience in eye care, specifically in the realm of vision correction. The company operates primarily in the field of personalized vision treatment solutions, leveraging advanced technology to ensure precision and improved outcomes for individuals undergoing vision correction procedures, particularly cataract surgery.

Segments

1. Cataract Surgery Solutions:
This is the primary segment of Rxsight Inc. that encompasses innovative technologies and products aimed at enhancing cataract surgery. The emphasis is on creating a personalized surgical experience for each patient by utilizing advanced measurement systems and devices.

2. Clinical Services:
In addition to products aimed at surgical procedures, Rxsight also provides a range of clinical services. This may involve training programs for surgeons and healthcare providers, enabling them to use Rxsights technologies effectively and ensuring the highest standards of patient care.

3. Patient Experience and Support:
Rxsight focuses on improving patient satisfaction through enhanced pre-operative and post-operative support. This segment includes educational resources and tools for patients, ensuring they are well-informed about their procedures and recovery processes.

Products

1. Novel Measurement Systems:
Rxsight has developed an advanced measurement system designed to provide precision in determining the proper intraocular lens (IOL) for individual patients. These systems aim to significantly reduce the variability in outcomes associated with traditional measurement techniques.

2. Personalized Intraocular Lenses (IOLs):
The company offers a range of IOL products that are tailored to meet the specific visual needs of patients undergoing cataract surgery. These lenses are designed with advanced optics and materials that enhance visual acuity and reduce dependency on corrective eyewear post-surgery.

3. Vision Correction Technologies:
Rxsight’s technologies may also extend into other areas of vision correction, including astigmatism management and presbyopia correction. This could involve the development of specialized lenses that address specific refractive errors.

Services

1. Surgeon Training and Support Services:
Rxsight provides educational programs, workshops, and training sessions for eye care professionals. This ensures that surgeons are adept in utilizing the companys technologies, thereby optimizing surgical outcomes.

2. Patient Education and Engagement:
The company emphasizes the importance of patient education regarding their eye health and vision correction options. This may include interactive tools, informational materials, and consultations that empower patients and help them make informed decisions.

3. Clinical Partnerships:
Rxsight collaborates with healthcare institutions and professionals to further develop its technologies and enhance clinical practices. Such partnerships may involve research and clinical trials to validate the efficacy and benefits of its products.

Conclusion

Rxsight Inc. is at the forefront of innovation in the ophthalmology sector, particularly concerning cataract surgery. With a focus on personalized solutions through advanced technology, the company aims to improve surgical precision and patient outcomes significantly. By integrating cutting-edge products with comprehensive support services for both healthcare providers and patients, Rxsight Inc. is dedicated to enhancing the overall patient experience in vision correction.


Composition of Rxsight Inc Revenues by Segments

 
L D D    7.71 % of total Revenue
LAL    88.65 % of total Revenue
Service Warranty Service Contracts And Accessories    4.93 % of total Revenue

Q1 three months ended (Mar 31 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
L D D 2.35 7.71 %
LAL 27.04 88.65 %
Service Warranty Service Contracts And Accessories 1.51 4.93 %
Total 30.50 100 %




Q1 three months ended (Mar 31 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
L D D -74.96 % -
LAL -0.55 % -
Service Warranty Service Contracts And Accessories 14.1 % -
Total -18.3 % -




Q1 three months ended (Mar 31 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total -15.88 -




Q1 three months ended (Mar 31 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total - -




Annual Report on Rxsight Inc Divisions, Sales by Country

 
L D D   L D D Segment contribution to total sales 15.42 % of total Revenue
LAL   LAL Segment contribution to total sales 80.64 % of total Revenue
Service Warranty Service Contracts And Accessories   Service Warranty Service Contracts And Accessories Segment contribution to total sales 4.29 % of total Revenue


Twelve months ended 2025
RXST s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
L D D 20.67 15.42 %
LAL 108.06 80.64 %
Service Warranty Service Contracts And Accessories 5.75 4.29 %
Total 134.01 100 %


Twelve months ended 2025
RXST s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total -38.94 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
L D D -47.94 % -
LAL 11.98 % -
Service Warranty Service Contracts And Accessories 54.27 % -
Total -3.55 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.